TailorMed, an end-to-end health tech platform providing the largest affordability network across the United States, has secured $40 million in equity and debt financing to transform medication access, affordability, and adherence.
According to the company’s announcement, the funding round was backed by new investors Windham Capital Partners, Impact Fund, BrightEdge, and Samsung Next, alongside investment arms of OSF Healthcare, Providence Ventures, Inception Health, UH Ventures, UnityPoint Health Ventures, and Ballad Ventures.
Existing investors Sanara Ventures, Accelmed, Triventures, Bridges, and Almeda Ventures also participated in the funding round, with Poalim-tech, part of Bank Hapoalim, leading the debt facility.
Co-founded in 2016 by Srulik Dvorsky and Adam Siton, TailorMed focuses on increasing access to high-quality care by removing all the common barriers along patients’ journeys. This allows every patient, regardless of their medical conditions, to get the vital treatment they need at an affordable cost.
TailorMed Platform
TailorMed’s disease and therapy-agnostic platform is designed to integrate seamlessly with any electronic health record (HER), practice, or pharmacy management system through a data feed or an API.
The platform blends patient insights, intelligent matching, and modern financial navigation tools to optimize resource use in healthcare delivery. It also provides critical analytics and reporting to help track key performance metrics, team productivity, and patient population information.
